Sign in
Taking people in AustriaPhase 1

Scanning a Transport Protein in Healthy Adults and Alzheimer's Patients

Uses a PET scan to measure a protein's activity in healthy adults and Alzheimer's patients.

Key facts

Who runs it
Medical University Of Vienna
Where
Vienna, AustriaSee the site
Registry title
A prospective, single-center phase I pilot study to assess the tissue activity of multidrug resistance-associated protein 1 with positron emission tomography
Status
Recruiting
Phase
Phase 1
People taking part
40 people, planned
Started
5 Sept 2022
Expected to end
1 Jan 2031
Type of study
Interventional
Record updated
17 January 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy volunteers and people with Alzheimer's disease. It studies the activity of multidrug resistance-associated protein 1 in tissue with positron emission tomography.

Age
18 years or older
Sex
All sexes can join.

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • How old are you?

Where in Austria

  • Medical University of ViennaVienna, AustriaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Scanning a Transport Protein in Healthy Adults and Alzheimer's PatientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2024-517851-11-00, who can take part
Record updated
17 January 2025